An Overview of MSCP Psychopharmacology Programs
$10.00
Panelists include Gerardo Rodriguez-Menendez, Judi Steinman, Ryan Ernst, George Kapalka, Derek Phillips, Eric Silk, Steve Curtis, and Casey McDougall
Recorded on Friday, March 15th, 2024
Access provided upon registration on “My Courses” page
A robust research finding in regional and national studies is that at least 40% of persons with mental disorders cannot access mental health services, and pharmacotherapy, in particular. Nationally, about 60% of all counties, including 80%of all rural counties, do not have a psychiatrist and 40% of persons needing mental health care services go untreated. The APA’s designated Master of Science
in Clinical Psychopharmacology (MSCP) programs for the provision of education and training in clinical psychopharmacology can be of great help in alleviating this national need. As clinical psychopharmacology has been accepted as a specialty within clinical psychology, education and training has evolved, and a variety of choices are offered to prospective students.
In this symposium, a review of APA designated MSCP programs will be provided. Participants will be able to obtain information pertinent to admission requirements, program overview, financial costs, curricular delivery methods, and outcomes of the designated MSCP programs. Time will also be allocated to discuss applicable state statues for prescribing psychologist licensure in New Mexico, Louisiana, Illinois, Idaho and Iowa. Scholarship and career opportunities in clinical psychopharmacology with the Department of Defense, Indian Health Service, and National Health Service Corps will be also be presented.
When attended in full, this program offers 1.0 APA CEs for Psychologists.
Description
Panelists include Gerardo Rodriguez-Menendez, Judi Steinman, Ryan Ernst, George Kapalka, Derek Phillips, Eric Silk, Steve Curtis, and Casey McDougall
Recorded on Friday, March 15th, 2024
Access provided upon registration on “My Courses” page
A robust research finding in regional and national studies is that at least 40% of persons with mental disorders cannot access mental health services, and pharmacotherapy, in particular. Nationally, about 60% of all counties, including 80%of all rural counties, do not have a psychiatrist and 40% of persons needing mental health care services go untreated. The APA’s designated Master of Science
in Clinical Psychopharmacology (MSCP) programs for the provision of education and training in clinical psychopharmacology can be of great help in alleviating this national need. As clinical psychopharmacology has been accepted as a specialty within clinical psychology, education and training has evolved, and a variety of choices are offered to prospective students.
In this symposium, a review of APA designated MSCP programs will be provided. Participants will be able to obtain information pertinent to admission requirements, program overview, financial costs, curricular delivery methods, and outcomes of the designated MSCP programs. Time will also be allocated to discuss applicable state statues for prescribing psychologist licensure in New Mexico, Louisiana, Illinois, Idaho and Iowa. Scholarship and career opportunities in clinical psychopharmacology with the Department of Defense, Indian Health Service, and National Health Service Corps will be also be presented.
When attended in full, this program offers 1.0 APA CEs for Psychologists.
